Inventor · disambiguated record
Zaifang Ren
Also filed as: REN ZAIFANG
5 granted patents·3 pending applications·18 citations·filing 2019–2025
73Inventor score
Top patents by PatentIndex Score
8 records- 0195US11584751B1Substituted imidazoles as GLP-1 receptor agonistsECCOGENE SHANGHAI CO LTD·Filed 2021·Granted Feb 21, 2023·14 cites·25 claims
- 0283US12037339B2Substituted imidazoles as GLP-1 receptor agonistsECCOGENE INC·Filed 2021·Granted Jul 16, 2024·1 cites·34 claims
- 0383US11286248B2Pyrazine-2(1H)-ketone compound acting as FGFR inhibitorZHANGZHOU PIEN TZE HUANG PHARM·Filed 2019·Granted Mar 29, 2022·3 cites·18 claims
- 0475US2025059192A1Substituted imidazoles as glp-1 receptor agonistsECCOGENE INC·Filed 2024·Application pending·0 cites
- 0572US11964942B2SSAO inhibitors and use thereofECCOGENE SHANGHAI CO LTD·Filed 2022·Granted Apr 23, 2024·0 cites·21 claims
- 0670US11472769B2SSAO inhibitors and use thereofECCOGENE SHANGHAI CO LTD·Filed 2020·Granted Oct 18, 2022·0 cites·22 claims
- 0763US2025326721A1Ssao inhibitors and use thereofECCOGENE INC·Filed 2025·Application pending·0 cites
- 0856US2022348564A1Phenyl-[1,3]dioxolo[4,5-c]pyridinyl-phenyl-, phenyl-[1,3]dioxolo[4,5-c]pyridinyl-heteroaryl-, or phenyl-(1,3)dioxo[4,5-c]pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo[d]imidazole-carboxylic acid derivatives and methods of using sameECCOGENE SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →